1078 related articles for article (PubMed ID: 28278513)
1. IL-6 Enhances Osteocyte-Mediated Osteoclastogenesis by Promoting JAK2 and RANKL Activity In Vitro.
Wu Q; Zhou X; Huang D; Ji Y; Kang F
Cell Physiol Biochem; 2017; 41(4):1360-1369. PubMed ID: 28278513
[TBL] [Abstract][Full Text] [Related]
2. HIF-1α facilitates osteocyte-mediated osteoclastogenesis by activating JAK2/STAT3 pathway in vitro.
Zhu J; Tang Y; Wu Q; Ji YC; Feng ZF; Kang FW
J Cell Physiol; 2019 Nov; 234(11):21182-21192. PubMed ID: 31032948
[TBL] [Abstract][Full Text] [Related]
3. Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis.
Kim HJ; Kim HJ; Choi Y; Bae MK; Hwang DS; Shin SH; Lee JY
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909508
[TBL] [Abstract][Full Text] [Related]
4. Vibration enhances osteoclastogenesis by inducing RANKL expression via NF-κB signaling in osteocytes.
Sakamoto M; Fukunaga T; Sasaki K; Seiryu M; Yoshizawa M; Takeshita N; Takano-Yamamoto T
Bone; 2019 Jun; 123():56-66. PubMed ID: 30902792
[TBL] [Abstract][Full Text] [Related]
5. Shear stress inhibits IL-17A-mediated induction of osteoclastogenesis via osteocyte pathways.
Liao C; Cheng T; Wang S; Zhang C; Jin L; Yang Y
Bone; 2017 Aug; 101():10-20. PubMed ID: 28414140
[TBL] [Abstract][Full Text] [Related]
6. Iron Overload-Induced Osteocyte Apoptosis Stimulates Osteoclast Differentiation Through Increasing Osteocytic RANKL Production In Vitro.
Yang J; Dong D; Luo X; Zhou J; Shang P; Zhang H
Calcif Tissue Int; 2020 Nov; 107(5):499-509. PubMed ID: 32995951
[TBL] [Abstract][Full Text] [Related]
7. MLO-Y4 osteocyte-like cells support osteoclast formation and activation.
Zhao S; Zhang YK; Harris S; Ahuja SS; Bonewald LF
J Bone Miner Res; 2002 Nov; 17(11):2068-79. PubMed ID: 12412815
[TBL] [Abstract][Full Text] [Related]
8. Osteocytes produce interferon-β as a negative regulator of osteoclastogenesis.
Hayashida C; Ito J; Nakayachi M; Okayasu M; Ohyama Y; Hakeda Y; Sato T
J Biol Chem; 2014 Apr; 289(16):11545-11555. PubMed ID: 24610813
[TBL] [Abstract][Full Text] [Related]
9. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway.
Wijenayaka AR; Kogawa M; Lim HP; Bonewald LF; Findlay DM; Atkins GJ
PLoS One; 2011; 6(10):e25900. PubMed ID: 21991382
[TBL] [Abstract][Full Text] [Related]
10. AG490 inhibits NFATc1 expression and STAT3 activation during RANKL induced osteoclastogenesis.
Li CH; Zhao JX; Sun L; Yao ZQ; Deng XL; Liu R; Liu XY
Biochem Biophys Res Commun; 2013 Jun; 435(4):533-9. PubMed ID: 23665018
[TBL] [Abstract][Full Text] [Related]
11. RANKL downregulates cell surface CXCR6 expression through JAK2/STAT3 signaling pathway during osteoclastogenesis.
Li C; Zhao J; Sun L; Yao Z; Liu R; Huang J; Liu X
Biochem Biophys Res Commun; 2012 Dec; 429(3-4):156-62. PubMed ID: 23142594
[TBL] [Abstract][Full Text] [Related]
12. Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes.
Choe JY; Park KY; Park SH; Lee SI; Kim SK
Arthritis Res Ther; 2013 Feb; 15(1):R26. PubMed ID: 23406906
[TBL] [Abstract][Full Text] [Related]
13. IL-6 alters osteocyte signaling toward osteoblasts but not osteoclasts.
Bakker AD; Kulkarni RN; Klein-Nulend J; Lems WF
J Dent Res; 2014 Apr; 93(4):394-9. PubMed ID: 24492932
[TBL] [Abstract][Full Text] [Related]
14. Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement.
Shu R; Bai D; Sheu T; He Y; Yang X; Xue C; He Y; Zhao M; Han X
PLoS One; 2017; 12(1):e0167312. PubMed ID: 28081119
[TBL] [Abstract][Full Text] [Related]
15. Effect of TNF-
Ohori F; Kitaura H; Marahleh A; Kishikawa A; Ogawa S; Qi J; Shen WR; Noguchi T; Nara Y; Mizoguchi I
J Immunol Res; 2019; 2019():9716758. PubMed ID: 31341915
[TBL] [Abstract][Full Text] [Related]
16. Pulsed electromagnetic fields regulate osteocyte apoptosis, RANKL/OPG expression, and its control of osteoclastogenesis depending on the presence of primary cilia.
Wang P; Tang C; Wu J; Yang Y; Yan Z; Liu X; Shao X; Zhai M; Gao J; Liang S; Luo E; Jing D
J Cell Physiol; 2019 Jul; 234(7):10588-10601. PubMed ID: 30422320
[TBL] [Abstract][Full Text] [Related]
17. Irradiation-induced osteocyte damage promotes HMGB1-mediated osteoclastogenesis in vitro.
He F; Bai J; Wang J; Zhai J; Tong L; Zhu G
J Cell Physiol; 2019 Aug; 234(10):17314-17325. PubMed ID: 30786022
[TBL] [Abstract][Full Text] [Related]
18. AG490 suppresses interleukin-34-mediated osteoclastogenesis in mice bone marrow macrophages.
Cheng X; Wan QL; Li ZB
Cell Biol Int; 2017 Jun; 41(6):659-668. PubMed ID: 28378938
[TBL] [Abstract][Full Text] [Related]
19. Iron overload induced osteocytes apoptosis and led to bone loss in Hepcidin
Ma J; Wang A; Zhang H; Liu B; Geng Y; Xu Y; Zuo G; Jia P
Bone; 2022 Nov; 164():116511. PubMed ID: 35933095
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 inhibits receptor activator of nuclear factor kappaB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine727 phosphorylation of signal transducer and activator of transcription 3.
Duplomb L; Baud'huin M; Charrier C; Berreur M; Trichet V; Blanchard F; Heymann D
Endocrinology; 2008 Jul; 149(7):3688-97. PubMed ID: 18403479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]